# Metabolic-syndrome verdicts — how ATLAS judges every pattern

Reviewed 2026-09-27. **Provisional editorial verdicts** on the ATLAS
product stance (avoid metabolic syndrome at all costs), with the source
base they rest on. Not a completed professional appraisal, systematic
review, or individual medical advice. Funding and interests remain
**not-verified** where stated. Verdicts are the operator's editorial
position; they are revised, not defended, as evidence moves.

## What metabolic syndrome is

**Grundy et al. 2005 — AHA/NHLBI Scientific Statement; Circulation
112(17):2735–52; PMID 16286935.** Diagnosis requires three of five:
waist circumference ≥102 cm (men) / ≥88 cm (women); triglycerides
≥150 mg/dL; HDL <40/<50 mg/dL; blood pressure ≥130/≥85 mmHg; fasting
glucose ≥100 mg/dL (each also met by drug treatment for it).
[Statement](https://pubmed.ncbi.nlm.nih.gov/16286935/)

## Why the low-carb family gets "fights it"

**Volek & Feinman 2005-family reviews:** carbohydrate restriction has
a more favorable impact on the metabolic syndrome than a low-fat
diet.

- **Volek 2008 — Prog Lipid Res; PMID 18396172.** Carbohydrate
  restriction induces a unique metabolic state positively affecting
  atherogenic dyslipidemia (triglycerides down, HDL up), fatty-acid
  partitioning, and metabolic-syndrome markers. [Review](https://pubmed.ncbi.nlm.nih.gov/18396172/)
- **Volek et al. 2009 — Lipids 44(4):297–309; PMID 19082851.** Argues
  carbohydrate restriction improves all features of the metabolic
  syndrome more effectively than low-fat diets. [Review](https://pubmed.ncbi.nlm.nih.gov/19082851/)

Honest limits: these are reviews and trials largely of 6–12 month
duration; long-term strict-elimination data are thin; LDL responses
to low-carb diets vary between individuals ("lean mass
hyper-responders" remain debated). Liver-fat RCT context lives on the
[Science page](/science/) (including the keto-vs-Mediterranean liver
fat trial).

**Medication caution (general clinical caution, no single citation
verified for this review):** people on insulin, sulfonylureas, or
blood-pressure medication who sharply cut carbohydrates can develop
hypoglycemia or hypotension. Involve a doctor — this is the note on
the Lion verdict card.

## Why the plant patterns get "protects on average"

**Rizzo et al. 2011 — Diabetes Care 34(5):1225–7; Adventist Health
Study 2.** Metabolic-syndrome prevalence in ~700 participants: 39.7%
nonvegetarian, 37.6% semivegetarian, 25.2% vegetarian (P for trend
<0.001). [Cohort](https://pmc.ncbi.nlm.nih.gov/articles/PMC3114510/)

Honest limits: cohort data show association, not causation;
Adventist cohorts differ from general populations in lifestyle
factors beyond diet (alcohol, smoking, activity). A refined-carbohydrate
vegetarian or vegan diet (sugary drinks, white flour, seed oils) can
still be metabolically harmful — the verdicts say "whole foods
decide" for this reason. Vegans additionally need a reliable B12
source (see the planner's B12 note).

## Verdict table

| Pattern | Public verdict | Rests on |
| --- | --- | --- |
| Lion | Fights it head-on (reset framing, medication note) | Carb-restriction cluster above |
| BBE | Fights it (same mechanism, wider list) | Carb-restriction cluster above |
| Carnivore + Pesce | Fights it (rotation room) | Carb-restriction cluster above |
| Ketovore | Fights it (portions decide carb total) | Carb-restriction cluster above |
| Whole-food mix | Protects, if built on whole foods | Rizzo gradient + whole-food principle |
| Vegetarian | Protects on average; whole foods decide | Rizzo 2011 |
| Vegan | Protects when whole-food; watch B12 | Rizzo 2011 + NIH B12 fact sheet (planner link) |

## Interpretation limits

No head-to-head trial compares all seven ATLAS patterns on
metabolic-syndrome incidence; the verdicts combine trial clusters
(low-carb) with cohort gradients (plant patterns) and the operator's
editorial judgment. Verdict language is deliberately simple for the
public layer; this file is the professional record of what the words
rest on and where they could break.